Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05857995 · ClinicalTrials.gov registry record · NA
Precision Lung Cancer Survivorship Care Intervention
A NA study of Lung Cancer and Cancer, Lung, sponsored by Jerod L Stapleton, PhD.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05857995 is a NA study of Lung Cancer and Cancer, Lung that is actively recruiting participants, run by Jerod L Stapleton, PhD. The registered enrollment target is 300 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05857995, a NA study of Lung Cancer and Cancer, Lung, is actively recruiting participants, sponsored by Jerod L Stapleton, PhD.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program
Study Locations (1)
Kentucky
- Markey Cancer Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-08-16 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05857995
The ClinicalTrials.gov registry entry for NCT05857995 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (68% lower). The listed sponsor is Jerod L Stapleton, PhD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT05857995 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT05857995 about?
NCT05857995 is a clinical study titled "Precision Lung Cancer Survivorship Care Intervention". The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. Th...
What is the current status of trial NCT05857995?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-08-16. Estimated completion is 2028-03-31.
What conditions does trial NCT05857995 study?
This clinical trial studies the following conditions: Lung Cancer, Cancer, Lung, Pulmonary Neoplasm, Pulmonary Cancer, Neoplasms, Lung.
What interventions are being tested in trial NCT05857995?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05857995?
This trial is sponsored by Jerod L Stapleton, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05857995 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.